Company overview
Just - Evotec Biologics is a CDMO providing end-to-end development and cGMP manufacturing for antibodies, next-generation biologics, and biosimilars. They specialize in continuous manufacturing technology to reduce costs and improve access to affordable biotherapeutics, with facilities in Seattle, Redmond (US), and Toulouse (France). Services span discovery using AI platforms like J.HAL and J.MD, process development, and clinical-to-commercial production up to 2,000+ kg/year.
Just Evotec Biologics is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, CDMO & Manufacturing partner serving United States & Americas. Core focus areas include just evotec biologics, biologics cdmo, continuous manufacturing, antibody development, biosimilars manufacturing.
Industry categories: Life Science Reagents, CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Just Evotec Biologics include Cdmo — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.evotec.com/solutions/just-evotec-biologics
- Categories
- Life Science Reagents, CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- just evotec biologics, biologics cdmo, continuous manufacturing, antibody development, biosimilars manufacturing
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What biologics manufacturing capabilities does Just - Evotec Biologics offer?
- They provide cGMP biomanufacturing from early clinical to commercial scale, including continuous manufacturing at J.POD facilities in Redmond (up to 2,000+ kg/year), J.PLANT Seattle for early-phase, and a new site in Toulouse, France, with process development under one roof.
- What discovery and development technologies do they use?
- Just - Evotec Biologics employs AI-driven platforms like J.HAL for antibody discovery, J.MD for molecular design optimization, and additional capabilities from Evotec including phage display and B-cell technologies for improved developability and manufacturability.
- What are their regulatory and geographic capabilities?
- They offer cGMP-compliant manufacturing at US sites (Seattle, Redmond) and Europe (Toulouse, France), leveraging continuous manufacturing for cost reduction to $50/gram or lower, with global network support through Evotec for integrated biologics activities.
Related editorial coverage
- FDA Approves 17 Drugs with Continuous Manufacturing: Implications for Pharma
- FDA Continuous Manufacturing: Key Insights on Drug Quality & Supply Chain
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
Explore lab tools and QA/QC resources for R&D teams.
